Education
About Us
Working with TipRanks
Follow Us
Kenvue, Inc. (KVUE)
NYSE:KVUE
KVUE Stock Chart & Stats
Day’s Range― - ―
52-Week Range$17.67 - $24.46
Previous CloseN/A
Volume2.33M
Average Volume (3M)17.36M
Market Cap
$45.22B
Enterprise Value$49.18B
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)43.9
Beta0.39
Next Earnings
Jul 17, 2025EPS Estimate
0.29Next Dividend Ex-Date
May 14, 2025Dividend Yield3.46%
Share Statistics
EPS (TTM)0.24
Shares Outstanding1,918,691,200
10 Day Avg. Volume17,064,094
30 Day Avg. Volume17,361,053
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
Price to Cash Flow (P/CF)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap1.09
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda15.53
Forecast
1Y Price Target
$24.39Price Target Upside5.54% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering12
---
Bulls Say, Bears Say
Bulls Say
EarningsKVUE Q1 sales and adjusted EPS beat expectations, with KVUE one of the few names across Consumer Staples to beat and largely reiterate guidance this earnings season.
InnovationThe company is committed to bringing 40% more innovation in 2025 compared to 2024 to strengthen its portfolio through adjacent categories and premiumization.
Operational IndependenceKenvue is near the completion of exiting its remaining transition service agreements, moving towards full operational independence from JNJ, which streamlines processes and focuses on consumer health.
Bears Say
Activist PressureKVUE remains under pressure by three activists due to underperformance in its core business segments.
Distribution ChallengesNear-term challenges exist with disruption at its distribution network within APAC, especially in China, and a weaker start to the cough, cold, & flu season in the US and China.
Sales PerformanceSkin Health & Beauty sales fell 2% in 2024 despite a 20% hike in marketing spend and are down 4% at U.S. retail through mid-March 2025.
---
Ownership Overview
1.18% Insiders
36.18% Mutual Funds
0.56% Other Institutional Investors
35.72% Public Companies and
Individual Investors
KVUE FAQ
What was Kenvue, Inc.’s price range in the past 12 months?
Kenvue, Inc. lowest stock price was $17.67 and its highest was $24.46 in the past 12 months.
What is Kenvue, Inc.’s market cap?
Kenvue, Inc.’s market cap is $45.22B.
When is Kenvue, Inc.’s upcoming earnings report date?
Kenvue, Inc.’s upcoming earnings report date is Jul 17, 2025 which is in 69 days.
How were Kenvue, Inc.’s earnings last quarter?
Kenvue, Inc. released its earnings results on May 08, 2025. The company reported $0.24 earnings per share for the quarter, beating the consensus estimate of $0.227 by $0.013.
Is Kenvue, Inc. overvalued?
According to Wall Street analysts Kenvue, Inc.’s price is currently Undervalued.
Does Kenvue, Inc. pay dividends?
Kenvue, Inc. pays a Quarterly dividend of $0.204 which represents an annual dividend yield of 3.46%. See more information on Kenvue, Inc. dividends here
What is Kenvue, Inc.’s EPS estimate?
Kenvue, Inc.’s EPS estimate is 0.29.
How many shares outstanding does Kenvue, Inc. have?
Kenvue, Inc. has 1,918,691,200 shares outstanding.
What happened to Kenvue, Inc.’s price movement after its last earnings report?
Kenvue, Inc. reported an EPS of $0.24 in its last earnings report, beating expectations of $0.227. Following the earnings report the stock price went up 4.111%.
Which hedge fund is a major shareholder of Kenvue, Inc.?
Currently, no hedge funds are holding shares in KVUE
---
Kenvue, Inc. Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$24.39 (5.54% Upside)
$24.39 (5.54% Upside)
Blogger Sentiment
Bullish
KVUE Sentiment 77%
Sector Average 67%
Sector Average 67%
Hedge Fund Trend
Increased
By 19.8M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $393.8K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▼ 0.4%
Last 30 Days ▲ 3.9%
Last 30 Days ▲ 3.9%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
28.41%
12-Months-Change
Fundamentals
Return on Equity
9.87%
Trailing 12-Months
Asset Growth
-8.08%
Trailing 12-Months
Company Description
Kenvue, Inc.
Kenvue, Inc. (KVUE) is a leading global consumer health company that operates across various sectors, including personal health care, skin health, and essential health products. The company is renowned for its portfolio of well-established brands, offering a range of products that cater to health and wellness needs. Kenvue is dedicated to delivering innovative solutions that enhance the quality of life for consumers around the world.
---
KVUE Company Deck
---
KVUE Earnings Call
Q1 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a mixed outlook for Kenvue, with strong execution of strategic plans and market share gains in certain segments overshadowed by organic sales declines and challenges in the Skin Health and Beauty segment. The impact of tariffs and foreign exchange rates also posed significant challenges.Read More>---
KVUE Revenue Breakdown
42.23% Self Care
30.33% Essential Health
27.43% Skin Health and Beauty
---
KVUE Stock 12 Month Forecast
Average Price Target
$24.39
▲(5.54% Upside)
Technical Analysis
---